Case Law of the Swiss Federal Patent Court
Case No. O2016_010 | Decision of 15 May 2019 | ‘Klarheitsprüfung bei Änderung der Patentansprüche’
Case No. O2016_011 | Decision of 15 May 2019 | ‘Klarheitsprüfung bei Änderung der Patentansprüche’
Loepfe had sued Uster Technologies AG for nullity of EP 2 347 250 (see EPO Register and Swissreg) and a divisional thereof, i.e.
Case No. O2016_001 | Decision of 27 June 2019
We had reported about the main hearing in this matter on this Blog here.
Case No. S2019_003 | Decision of 6 February 2019
Case No. S2019_003 | Decision of 11 July 2019
These two decisions in summary proceedings are heavily redacted — which is an exception to the rule.
Case No. O2016_017 | Decision of 21 June 2019
The patent at stake is, again, MundiPharma‘s EP 2 425 825 B9; see EPO Register and Swissreg.
All European patent attorneys are members of the Institute of Professional Representatives before the European Patent Office (epi). epi represents the interests of its members in relation to the EPO.
The annual INGRES event of 2 July 2019 (‘Praxis des Immaterialgüterrechts’) has been very interesting and enjoyable, as always. I am not intending to anticipate the full report about the event that will be prepared by Estelle SEILER for publication in sic!, but there was one specific discussion following-up on Susanna RUDER‘s presentation that I am still digesting.
Case No. O2017_015 | Hearing of 1 July 2019 (canceled)
First things first: The hearing scheduled for today did not take place.
Case No. 4A_56/2019 (Supreme Court) | Decision of 27 May 2019 on appeal against O2017_024 (FPC) | Order of 11 December 2018
The Supreme Court had to deal with an appeal against an (unpublished) order issued by the Administrative Commission (AC) of the FPC in case no.
Case No. O2018_016 | Hearing of 25 June 2019
Laurastar and Innosteam are litigating about ownership of two PCT applications, WO 2018/006994 A1 and WO 2018/036653 A1; see the EPO Register here and here.
Case No. O2016_016 | Decision of 6 June 2019
The patent at stake is MundiPharma‘s EP 2 425 825 B9; see EPO Register and Swissreg.
Case No. O2018_003 ¦ Hearing of 17 June 2019
The patent in suit is Lilly‘s EP 1 313 508 B1; see the EPO Register and Swissreg for further information.
Case No. O2016_017 | Hearing of 3 June 2019
The patent at stake is MundiPharma‘s EP 2 425 825 B9; see EPO Register and Swissreg.